Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

6.63
-0.1700-2.50%
Post-market: 6.630.00000.00%16:34 EDT
Volume:1.14M
Turnover:7.53M
Market Cap:672.03M
PE:-9.33
High:6.81
Open:6.81
Low:6.52
Close:6.80
Loading ...
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities